Total Funding
67
74
Total FundingSeed raised
Growth Score 67 in past quarter
-3 pts
Heat Score 74 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
110635
Cellartgen is a biotechnology company that develops regenerative medical technology that combines organoids and functional biomaterials.
- Seung-Woo Cho: cellArtgen
About the Company
Cellartgen is a biotechnology company that develops regenerative medical technology that combines organoids and functional biomaterials. The company aims to realize personalized regenerative medicine through the convergence of organoid and biomaterial technologies. Through cutting-edge biotechnology that fuses organoids with biomaterials. It also
aims to assist in the development of treatments for intractable and rare diseases, and furthermore, to provide many people with new opportunities for life by developing regenerative therapies for the recovery of damaged organs.